CAR-T therapy

Showing 5 posts of 5 posts found.


Novartis’ CAR T therapy Kymriah nails main goal in follicular lymphoma

August 4, 2020
Manufacturing and Production, Research and Development CAR-T therapy, Cancer, Kymriah, Novartis, car t therapy

Novartis is celebrating the success of its one-time CAR T therapy Kymriah (tisagenlecleucel) in patients with relapsed or refractory (r/r) …


Top Ten most popular articles on this week!

August 16, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Air pollution, CAR-T therapy, HIV, Kymriah, Medicare, Novartis, Yescarta, Zolgensma

Novartis’ faulty data scandal dominated the headlines this week, as the Swiss firm faced fierce backlash over covering up the …


Scientists use duoCAR-T therapy to fight HIV

August 9, 2019
Medical Communications AIDS, CAR-T therapy, HIV, health, immunotherapy, pharma

Researchers from the University of Pittsburgh, working with the biotech Lentigen, have found that an advanced form of CAR-T therapy …


Precision cancer treatment for dogs moves towards human testing

January 29, 2019
Manufacturing and Production CAR-T therapy, Cancer, Precision Medicine, car t therapy, dogs, t cells, t-cells

Scientists at the University of Missouri have developed a patient specific, precision medicine treatment for bone cancer in dogs. The …


Researchers launch CAR-T cell therapy trial in head and neck cancer

December 9, 2015
Research and Development CAR-T, CAR-T therapy, Cancer, head and neck cancers, oncology R&D

A pioneering trial is beginning in London, where doctors are harnessing patients’ own immune systems to find a new effective …

Latest content